The Impact of Insulin Glargine on Blood Glucose Control during On-Pump Beating Coronary Artery Bypass Surgery in Diabetic Patients: A Single-Blind Randomized Controlled Trial
Archives of Anesthesia and Critical Care · 20.06.2026
DOI: 10.18502/aacc.v12i4.21791 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Archives of Anesthesia and Critical Care, online erschienen am 20.06.2026. Verfasst von Raheleh Ganjali und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Diabetes mellitus in subjects of coronary artery bypass grafting (CABG) surgery is associated with increased morbidity and mortality. Therefore, in recent years, glycemic monitoring and control have been the focus of clinical research. This study aimed to determine the impact of insulin glargine on the management of blood glucose during the perioperative period of on-pump coronary artery bypass graft in diabetic patients.
Methods
In a randomized clinical trial, 80 patients with type 2 diabetes, candidates for elective CABG with a cardiopulmonary pump, were randomly separated into two groups. The intervention group received 0.2 units/kg of insulin glargine 2 hours before induction of anesthesia plus usual care. The control group received usual care. Usual care included injection of regular insulin before, during, and after surgery in accordance with a changed Van den Berghe code. Blood glucose (BG) level, ICU and hospital length of stay (LOS), creatinine, white blood cell count (WBC), and postoperative complications, including infection and dehiscence, were evaluated between two groups.
Results
The BG of patients upon entrance (p=0.04), 16 (p=0.01), 20 (p=0.01), and 24 (p=0.01) hours after admission to the ICU was significantly lower in the intervention than in the control group. There was a significant difference in the average BG levels at different times (p
Zitieren
APA
Ganjali, R., Kahrom, M., Bijari, F., Tabari, M., Firoozjah, A. G., & Sheybani, S. (2026). The Impact of Insulin Glargine on Blood Glucose Control during On-Pump Beating Coronary Artery Bypass Surgery in Diabetic Patients: A Single-Blind Randomized Controlled Trial. Archives of Anesthesia and Critical Care. https://doi.org/10.18502/aacc.v12i4.21791
Vancouver
Ganjali R, Kahrom M, Bijari F, Tabari M, Firoozjah AG, Sheybani S. The Impact of Insulin Glargine on Blood Glucose Control during On-Pump Beating Coronary Artery Bypass Surgery in Diabetic Patients: A Single-Blind Randomized Controlled Trial. Archives of Anesthesia and Critical Care. 2026. doi:10.18502/aacc.v12i4.21791
BibTeX
@article{Ganjali2026,
author = {Ganjali, Raheleh and Kahrom, Mahdi and Bijari, Fatemeh and Tabari, Masoomeh and Firoozjah, Ali Golchoobi and Sheybani, Shima},
title = {The Impact of Insulin Glargine on Blood Glucose Control during On-Pump Beating Coronary Artery Bypass Surgery in Diabetic Patients: A Single-Blind Randomized Controlled Trial},
journal = {Archives of Anesthesia and Critical Care},
year = {2026},
doi = {10.18502/aacc.v12i4.21791}
}
EUVIMED